MarketCap
Facebook
X
Telegram
Alphatec Holdings Operating Cycle | ATEC
Annual Operating Cycle Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 314 | 351 | 303 | 352 | 343 | 398 | 407 | 430 | 306 | 305 | 333 | 318 | 268 | 333 | 284 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 430 | 268 | 336 |
Quarterly Operating Cycle Alphatec Holdings
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 340 | - | 321 | 343 | - | 387 | 399 | 375 | - | 347 | 247 | 299 | - | 179 | 180 | 454 | - | 400 | 354 | 436 | - | 404 | 550 | 466 | - | 394 | 431 | 421 | - | 446 | 467 | 464 | - | 349 | 344 | 288 | 62.4 | 316 | 300 | 355 | 70.5 | 447 | 294 | 332 | 68.8 | 339 | 299 | 323 | 71.2 | 225 | 281 | 317 | 71 | 350 | 335 | 347 | 76.9 | 326 | 278 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 550 | 62.4 | 319 |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
267 | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
381 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
321 | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
156 | - | - | $ 10.2 M | USA |
 |
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M |  China |
 |
LENSAR
LNSR
|
231 | $ 5.6 | -2.78 % | $ 67 M | USA |
 |
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
220 | - | - | $ 475 M | USA |
 |
Aziyo Biologics
AZYO
|
205 | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
196 | - | -13.19 % | $ 166 K | USA |
 |
Outset Medical
OM
|
366 | $ 4.04 | -4.49 % | $ 61.5 K | USA |
 |
AxoGen
AXGN
|
279 | $ 39.49 | -0.6 % | $ 1.82 B | USA |
 |
Conformis
CFMS
|
216 | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
210 | $ 163.26 | 3.08 % | $ 11.5 B | USA |
 |
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | USA |
 |
Quanterix Corporation
QTRX
|
298 | $ 3.67 | -6.38 % | $ 156 M | USA |
 |
CryoLife, Inc.
CRY
|
212 | - | -4.14 % | $ 702 M | USA |
 |
Bruker Corporation
BRKR
|
271 | $ 60.45 | -2.74 % | $ 9.18 B | USA |
 |
Sintx Technologies
SINT
|
502 | $ 1.42 | -6.58 % | $ 3.94 M | USA |
 |
Soliton, Inc.
SOLY
|
455 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
TELA Bio
TELA
|
216 | $ 0.69 | -2.81 % | $ 32.4 M | USA |
 |
Neovasc
NVCN
|
130 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
133 | - | 14.99 % | $ 929 K | USA |
 |
Tactile Systems Technology
TCMD
|
124 | $ 27.48 | 0.15 % | $ 629 M | USA |
 |
TransMedics Group
TMDX
|
127 | $ 72.26 | 1.59 % | $ 2.46 B | USA |
 |
IRIDEX Corporation
IRIX
|
69.4 | $ 0.89 | -3.38 % | $ 15.1 M | USA |
 |
Tandem Diabetes Care
TNDM
|
284 | $ 17.12 | 1.3 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
224 | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
ClearPoint Neuro
CLPT
|
250 | $ 14.12 | -2.55 % | $ 400 M | USA |
 |
Viemed Healthcare
VMD
|
49 | $ 11.77 | 0.86 % | $ 458 M | USA |
 |
Avanos Medical
AVNS
|
212 | $ 24.99 | 0.04 % | $ 1.16 B | USA |
 |
Beyond Air
XAIR
|
137 | $ 5.16 | -5.67 % | $ 42.8 B | USA |
 |
Invacare Corporation
IVC
|
289 | - | - | $ 24.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
306 | $ 0.43 | -0.39 % | $ 60 M | USA |
 |
Cytosorbents Corporation
CTSO
|
212 | $ 0.36 | -0.39 % | $ 22.4 M | USA |
 |
NanoVibronix
NAOV
|
372 | - | - | $ 1.08 M | USA |
 |
NuVasive
NUVA
|
425 | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
79 | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
359 | - | - | $ 217 M | USA |
 |
Inogen
INGN
|
83.5 | $ 6.15 | -2.69 % | $ 164 M | USA |